Back to Capital World Investors Capital World Investors

VRTXVRTX
Showing 8 of 29 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in VERTEX PHARMACEUTICALS INC

Capital World Investors holds 26.1M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $13B as of 2026-Q2. The position was increased (+2.9% shares). VRTX represents 1.5% of Capital World Investors's portfolio.

Current Value

$13B

Current Shares

26.1M

Total Value Change

+$503.2M

Total Shares Change

-695,688

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
26.1M
+2.9%
$13B1.5%$496.73
52
2026-Q1
Decreased
25.4M
-0.6%
$11.3B1.5%$446.54
0
2025-Q4
Decreased
25.5M
-1.6%
$11.6B1.6%$453.36
0
2025-Q3
Decreased
25.9M
-9.8%
$10.1B1.4%$391.64
0
2025-Q2
Increased
28.7M
+0.7%
$12.8B1.9%$445.20
50
2025-Q1
Increased
28.5M
+0.7%
$13.8B2.2%$484.82
55
2024-Q4
Increased
28.3M
+5.7%
$11.4B1.7%$402.70
53
2024-Q3
Increased
26.8M
+0.4%
$12.5B1.9%$465.08
50

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used